Search Results - "Eisinger, Silke"

Targeting myeloid suppressive cells revives cytotoxic anti-tumor responses in pancreatic cancer by Sarhan, Dhifaf, Eisinger, Silke, He, Fei, Bergsland, Maria, Pelicano, Catarina, Driescher, Caroline, Westberg, Kajsa, Benitez, Itziar Ibarlucea, Hamoud, Rawan, Palano, Giorgia, Li, Shuijie, Carannante, Valentina, Muhr, Jonas, Önfelt, Björn, Schlisio, Susanne, Ravetch, Jeffrey V., Heuchel, Rainer, Löhr, Matthias J., Karlsson, Mikael C.I.

“…Immunotherapy for cancer that aims to promote T cell anti-tumor activity has changed current clinical practice, where some previously lethal cancers have now…”
Get full text

Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells by Eisinger, Silke, Sarhan, Dhifaf, Boura, Vanessa F., Ibarlucea-Benitez, Itziar, Tyystjärvi, Sofia, Oliynyk, Ganna, Arsenian-Henriksson, Marie, Lane, David, Wikström, Stina L., Kiessling, Rolf, Virgilio, Tommaso, Gonzalez, Santiago F., Kaczynska, Dagmara, Kanatani, Shigeaki, Daskalaki, Evangelia, Wheelock, Craig E., Sedimbi, Saikiran, Chambers, Benedict J., Ravetch, Jeffrey V., Karlsson, Mikael C. I.

“…Tumor-associated macrophages (TAMs) can have protumor properties, including suppressing immune responses, promoting vascularization and, consequently,…”
Get full text

Revealing the Secrets of Marco: A Target for Cancer Immunotherapy by Eisinger, Silke

“…Our immune system protects us from infectious agents and sustains the homeostasis in our body. However, the immune system can also play a role in initiation…”
Get full text

The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy by Ingelshed, Katrine, Spiegelberg, Diana, Kannan, Pavitra, Påvénius, Linnéa, Hacheney, Jessica, Jiang, Long, Eisinger, Silke, Lianoudaki, Danai, Lama, Dilraj, Castillo, Francisca, Bosdotter, Cecilia, Kretzschmar, Warren W, Al-Radi, Omayma, Fritz, Nicolas, Villablanca, Eduardo J, Karlsson, Mikael C I, Wermeling, Fredrik, Nestor, Marika, Lane, David P, Sedimbi, Saikiran K

“…The tumor suppressor protein p53 is mutated in close to 50% of human tumors and is dysregulated in many others, for instance by silencing or loss of p14 …”
Get full text